Cancer Research Training and Education Coordination
Cancer Research Training and Education Coordination
批准号:
10627028
负责人:
Rajagopal Ramesh
金额:
$14.1万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-05-01 至 2028-04-30
关键词:
American Cancer SocietyAwardCancer CenterCancer Center Support GrantCatchment AreaCenters of Research ExcellenceClinicalCommunity OutreachDirect CostsDoctor of PhilosophyEducationFacultyFundingGoalsGrantHealth ProfessionalInfrastructureInstitutionInvestmentsK-Series Research Career ProgramsLeadershipMalignant NeoplasmsMentorsMentorshipMinorityMinority GroupsMissionNCI Center for Cancer ResearchNCI-Designated Cancer CenterNative American Research Center for HealthOklahomaOncologyPathway interactionsPeer ReviewPersonsPlayPostdoctoral FellowProgram DevelopmentReportingResearchResearch PersonnelResearch Project GrantsResourcesRoleStudentsTrainingTraining and EducationUnderrepresented MinorityUnderrepresented PopulationsUnited States National Institutes of HealthWomanWorkanticancer researchcancer imagingcareercareer developmentcommunity engagementequity, diversity, and inclusionhigh schoolhigh school programmembernext generationprogramssummer internshipsummer researchsummer studenttraining projectundergraduate student
中文摘要
癌症研究培训与教育协调:摘要
斯蒂芬森癌症中心(SCC)是俄克拉荷马州唯一由NCI指定的癌症中心,在
使命驱动在培训下一代癌症生物医学研究人员和肿瘤学健康方面的作用
为国家(SCC集水区)和国家服务的专业人员。为了推进这一目标,SCC的
教育、培训和职业提升(ETCE)核心,由Rajagopal Ramesh博士领导,SCC Associate
教育和培训主任,为广泛的
为所有职业阶段的学生和实习生(高中、
本科生、研究生、博士后研究员、临床研究员和初级研究员)从事癌症-
相关项目。SCC在ETCE基础设施和资源方面进行了大量投资,并已
利用OUHSC机构资源促进和推进培训和职业发展。在.期间
在报告所述期间(2017-21),经贸委在推进其目标和宗旨方面取得了重大进展
通过增加培训资金来突出这一点。同行评审的培训资金总额增加了109%,
从9.83万美元到205万美元,自上次CCSG(年度,直接成本)以来。这包括七个新的NIH K奖项,两个新的
NIH F奖,以及两个新的P20生物医学研究卓越中心(Cobres)。第三个新的750万美元
(Total,DC)Cobre Grant开始指导SCC癌症成像研究人员2/15/22年2月15日(新资金说明
包括在总数中)。所有培训资金总额增加了115%,从107万美元增加到229万美元。总人数
所有培训项目从11个(2016年)增加到33个(2021年)。在ETCE的支持下,SCC获得了一名美国人
癌症学会-机构研究补助金(ACS-IRG),这是美国癌症学会于#年在全国范围内颁发的唯一一项此类赠款
2019年,支持年轻研究人员研究(IRG包括支持一名研究人员的ACS补充
来自代表不足的少数民族[URM]群体)。此外,SCC在#年获得了ACS分集的资金
癌症研究(ACS-DICR)暑期学生计划,支持8名URM本科生。这个
ETCE Core负责管理高中暑期研究项目(小CURE)和本科生(治愈)
学生,它与OUHSC的多个机构实体合作,将癌症研究的重点带到
各种其他暑期实习(如CRISP、INBRE、NARCH、SURE)以及指导(INBRE、Cobre、
OSCTR)计划。正如研究战略中强调的那样,ETCE与SCC研究密切合作
领导力,包括负责社区外联和参与以及多样性、公平的协理主任
和包容性,以加强妇女和历史上任职人数偏低群体的参与
教育渠道和职业发展方案(ETCE具体目标3)。
英文摘要
CANCER RESEARCH TRAINING AND EDUCATION COORDINATION: ABSTRACT
The Stephenson Cancer Center (SCC) is Oklahoma’s only NCI-designated cancer center and plays a critical
mission-driven role in training the next generation of cancer biomedical researchers and oncology health
professionals for the state (the SCC catchment area) and for the nation. To advance this goal, the SCC’s
Education, Training and Career Enhancement (ETCE) Core, led by Rajagopal Ramesh, PhD, SCC Associate
Director for Education and Training, provides important oversight, coordination and support for a wide range of
educational and mentorship activities for students and trainees in all career stages (high school,
undergraduate, graduate, postdoctoral fellows, clinical fellows, and junior investigators) conducting cancer-
related projects. The SCC has made significant investments in ETCE infrastructure and resources and has
leveraged OUHSC institutional resources to promote and advance training and career development. During the
reporting period (2017-21), ETCE has made significant progress in advancing its goal and aims, as is
highlighted through increases to training funding. Total peer-reviewed training funding increased by 109%,
from $983K to $2.05M, since last CCSG (annual, direct cost). This includes seven new NIH K awards, two new
NIH F awards, and two new P20 Centers for Biomedical Research Excellence (COBREs). A third new $7.5M
(total, DC) COBRE grant to mentor junior SCC cancer imaging researchers started 2/15/22 (new funding not
included in totals). Total all training funding increased by 115%, from $1.07M to $2.29M. The overall number of
all training projects increased from 11 (2016) to 33 (2021). With ETCE support, the SCC obtained an American
Cancer Society-Institutional Research Grant (ACS-IRG), the only such grant awarded nationally by ACS in
2019, to support young investigator research (the IRG includes an ACS supplement to support one investigator
from an underrepresented minority [URM] group). In addition, the SCC received funding for an ACS Diversity in
Cancer Research (ACS-DICR) summer student program to support eight URM undergraduate students. The
ETCE Core administers summer research programs for high school (CURE, Jr.) and undergraduate (CURE)
students, and it has partnered with multiple institutional entities at OUHSC to bring a cancer research focus to
various other summer internship (e.g., CRISP, INBRE, NARCH, SURE) as well as mentoring (INBRE, COBRE,
OSCTR) programs. As is highlighted in the Research Strategy, ETCE works closely with SCC research
leadership, including the Associate Directors for Community Outreach and Engagement and Diversity, Equity
and Inclusion, to enhance the participation of women and persons from historically underrepresented groups in
education pipeline and career development programs (ETCE Specific Aim 3).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineered Nanoformulation for Immune-modulation in Cancer
-
批准号:10719487
-
项目类别:
-
资助金额:$54.31万
-
财政年份:2023
-
负责人:Rajagopal Ramesh
-
依托单位:
Exosomes as carriers of cancer therapeutics
-
批准号:10312645
-
项目类别:
-
资助金额:$57.62万
-
财政年份:2021
-
负责人:Rajagopal Ramesh
-
依托单位:
ShEEP Request for CytoViva 3D Darkfield Hyperspectral Microscope
-
批准号:9906462
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Rajagopal Ramesh
-
依托单位:
An improved IL-24 gene-based therapeutic for cancer
-
批准号:10326352
-
项目类别:
-
资助金额:$34.39万
-
财政年份:2019
-
负责人:Rajagopal Ramesh
-
依托单位:
An improved IL-24 gene-based therapeutic for cancer
-
批准号:10544003
-
项目类别:
-
资助金额:$34.39万
-
财政年份:2019
-
负责人:Rajagopal Ramesh
-
依托单位:
Molecular Impact of Platinum Drugs on the Proteasome and SQSTM1_P62 Complexes_A Paradigm Shift in Resistance
-
批准号:10051382
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Rajagopal Ramesh
-
依托单位:
Molecular Impact of Platinum Drugs on the Proteasome and SQSTM1_P62 Complexes_A Paradigm Shift in Resistance
-
批准号:9478535
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Rajagopal Ramesh
-
依托单位:
HuR Targeted Nanotherapy for Lung Cancer
-
批准号:8601528
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2013
-
负责人:Rajagopal Ramesh
-
依托单位:
HuR Targeted Nanotherapy for Lung Cancer
-
批准号:8785610
-
项目类别:
-
资助金额:$38.02万
-
财政年份:2013
-
负责人:Rajagopal Ramesh
-
依托单位:
HuR Targeted Nanotherapy for Lung Cancer
-
批准号:8440451
-
项目类别:
-
资助金额:$40.24万
-
财政年份:2013
-
负责人:Rajagopal Ramesh
-
依托单位:
Small Animal Imaging Core
-
批准号:10455519
-
项目类别:
-
资助金额:$13.15万
-
财政年份:2012
-
负责人:Rajagopal Ramesh
-
依托单位:
Small Animal Imaging Core
-
批准号:10219282
-
项目类别:
-
资助金额:$14.61万
-
财政年份:2012
-
负责人:Rajagopal Ramesh
-
依托单位:
Preclinical Development and Testing of Multifunctional Tumor-Targeted Hybrid Nano
-
批准号:7853312
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2009
-
负责人:Rajagopal Ramesh
-
依托单位:
Preclinical Development and Testing of Multifunctional Tumor-Targeted Hybrid Nano
-
批准号:7568525
-
项目类别:
-
资助金额:$7.7万
-
财政年份:2009
-
负责人:Rajagopal Ramesh
-
依托单位:
Preclinical Development and Testing of Multifunctional Tumor-Targeted Hybrid Nano
-
批准号:7767687
-
项目类别:
-
资助金额:$7.62万
-
财政年份:2009
-
负责人:Rajagopal Ramesh
-
依托单位:
Systemic Non-Viral Gene Therapy for Cancer
-
批准号:7642448
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2008
-
负责人:Rajagopal Ramesh
-
依托单位:
Systemic Non-Viral Gene Therapy for Cancer
-
批准号:8054961
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2008
-
负责人:Rajagopal Ramesh
-
依托单位:
Systemic Non-Viral Gene Therapy for Cancer
-
批准号:7800284
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2008
-
负责人:Rajagopal Ramesh
-
依托单位:
Systemic Non-Viral Gene Therapy for Cancer
-
批准号:7530849
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2008
-
负责人:Rajagopal Ramesh
-
依托单位:
Evaluate the antiangiogenic properties of mda-7/IL-24
-
批准号:6822239
-
项目类别:
-
资助金额:$23.92万
-
财政年份:2004
-
负责人:Rajagopal Ramesh
-
依托单位:
海外基金